The Pharma Legal Handbook: Norway

22 May 2020
Book releases

DLA Piper Norway experts have authored the "The Pharma Legal Handbook: Norway" –  a practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Norway.

Published by Pharma Boardroom—a global leader in the provision of in-depth country reports on the pharmaceuticals industry—the Norwegian Handbook provides answers to essential questions relating to the local legal and regulatory environment for the pharma industry including manufacturing, marketing, pricing and reimbursement, clinical and preclinical trials, trademarks and patents.

The Handbook is a useful tool for pharma companies and practitioners operating in the pharmaceuticals business in Norway to stay in compliance with the various regulations applicable to the industry. 

The publication was prepared by partners Petter Bjerke and Line Voldstad, Lead Lawyer Katrine Lillerud and associate Magnus Sollie Gjerdalen.

For more information about the contents of the Handbook and/or applicable DLA Piper client discount, please contact Petter Bjerke or Line Voldstad, and to purchase your copy, click here.